Testicular Cancer and Platinum: A Double-Edged Sword

Development and validation of a predictive model for chemotherapy-associated thrombosis

Alok A. Khorana, Nicole M. Kuderer, Eva Culakova et al. · Blood · 2008 · 2.2K citations · Full text

Medicine, Hematology, Oncology +14

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Giancarlo Agnelli, Gualberto Gussoni, C. Bianchini et al. · The Lancet Oncology · 2009 · 598 citations

Medicine, Oncology, Pharmacology +13

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

Giancarlo Agnelli, Daniel J. George, Ajay K. Kakkar et al. · New England Journal of Medicine · 2012 · 533 citations

Medicine, Hematology, Pharmacology +12

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis

Russell Moore, Nelly G. Adel, Elyn Riedel et al. · Journal of Clinical Oncology · 2011 · 432 citations · Full text

Medicine, Hematology, Oncology +16

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma

A. Horwich, R.T.D. Oliver, P M Wilkinson et al. · British Journal of Cancer · 2000 · 109 citations · Full text

Medicine, Oncology, Pharmacology +12